Hospice News December 27, 2024
UnitedHealth Group (NYSE: UNH) subsidiary Optum entered a new waiver agreement that has delayed the deadline to complete its $3.3 billion acquisition of Amedisys (Nasdaq: AMED).
The agreement comes on the heels of an antitrust lawsuit that the U.S. Department of Justice (DOJ) filed last month to block the transaction due to concerns that it would reduce competition in the home health and hospice markets.
Expected to close in the fourth quarter of this year, the agreement extended the deadline until 10 days after a final court decision is issued in the lawsuit, or by Dec. 31, 2025, according to a filing with the U.S. Securities and Exchange Commission (SEC).
In the agreement, the companies each waived the right to...
Today's Sponsors
Today's Sponsor
